Skip to main content
. 2021 Feb 25;44(8):zsab044. doi: 10.1093/sleep/zsab044

Table 1.

Baseline characteristic of the participants according to trajectories of sleep quality

Sleep quality patterns determined by PSQI scores P
Normal-stable (n = 1697) Moderate-stable (n = 1157) Poor-stable (n = 320) Developing to poor (n = 84) Severely poor- stable (n = 89)
Men, % 984 (58.0) 555 (48.0) 111 (34.7) 21 (25.0) 30 (33.7) <0.001
Age, years 47.94 ± 7.11 49.09 ± 7.38 50.04 ± 7.77 49.64 ± 7.24 49.44 ± 8.05 <0.001
Education, %
 Lower: high school, or less 1295 (76.4) 891 (77.0) 275 (85.9) 77 (91.7) 79 (89.8) <0.001
 Higher: college, or above 400 (23.6) 266 (23.0) 45 (14.1) 7 (8.3) 9 (10.2)
Monthly household income, %
 <$2500 1144 (67.8) 799 (69.6) 238 (75.1) 67 (79.8) 71 (79.8) 0.004
 ≥$2500 544 (32.2) 349 (30.4) 79 (24.9) 17 (20.2) 18 (20.2)
Occupation, %
 Unemployment (homemaker, etc.) 840 (49.6) 659 (57.1) 227 (71.4) 57 (67.9) 58 (65.2) <0.001
 Manual labor 590 (34.8) 343 (29.7) 64 (20.1) 22 (26.2) 25 (28.1)
 Professional labor 265 (15.6) 152 (13.2) 27 (8.5) 5 (6.0) 6 (6.7)
Currently married, % 1622 (95.6) 1082 (93.5) 289 (90.3) 81 (96.4) 83 (93.3) 0.011
Currently smoking, % 419 (24.8) 222 (19.1) 65 (20.4) 11 (13.3) 17 (19.1) <0.001
Currently drinking, % 910 (53.7) 604 (52.2) 148 (46.3) 36 (42.9) 38 (42.7) 0.013
Moderate exercise, % 648 (38.6) 448 (39.4) 134 (42.1) 26 (32.5) 38 (43.2) 0.481
Disease diagnosis*, % 326 (19.2) 253 (21.8) 75 (23.1) 21 (25.0) 20 (22.5) 0.234
Sleep drug intake, % 42 (2.5) 63 (5.5) 44 (13.8) 15 (18.3) 31 (34.8) <0.001
Sleep duration, hour 6.9 ± 1.12 6.52 ± 1.22 6.14 ± 1.28 6.22 ± 1.63 6.18 ± 1.55 <0.001
BDI 5 [2-9] 7 [4-12] 9.5 [6-15] 10 [7-16] 14 [7-20] <0.001
BMI, kg/m2 24.67 ± 2.83 24.81 ± 2.89 24.65 ± 2.97 24.48 ± 2.92 24.69 ± 2.69 0.676
Total cholesterol, mg/dL 196.12 ± 35.3 196.69 ± 35.7 195.74 ± 33.56 193.74 ± 32.7 192.78 ± 34.89 0.821
HDL cholesterol, mg/dL 44.36 ± 9.52 44.84 ± 10.01 45.28 ± 9.59 45.61 ± 9.98 46.15 ± 9.48 0.187
LDL cholesterol, mg/dL 121.27 ± 31.43 121.28 ± 30.82 120.21 ± 30.96 117.04 ± 29.15 120.51 ± 32.49 0.777
SBP, mmHg 116.34 ± 16.12 116.63 ± 16.85 116.47 ± 17.73 117.39 ± 17.62 114.01 ± 16.48 0.665
DBP, mmHg 78.27 ± 11.19 77.91 ± 11.05 77.12 ± 11.64 77.86 ± 12.26 76.45 ± 11.65 0.320
Triglyceride, mg/dL 132 [97-186] 134 [97-186] 140 [97-187] 138 [100-189] 121 [89-158] 0.173
HbA1c, % 5.5 [5.3-5.8] 5.6 [5.3-5.8] 5.5 [5.3-5.8] 5.5 [5.3-5.8] 5.5 [5.3-5.9] 0.631
Fasting insulin, uIU/mL 6.8 [5.0-9.1] 6.9 [5.1-9.2] 6.6 [4.7-9.0] 7.1 [5.0-9.6] 6.5 [5.0-8.8] 0.437
Fasting glucose, mg/dL 83 [78-91] 83 [78-92] 82 [77-88] 83.5 [77-90] 82 [76-90] 0.226
High-sensitivity C-reactive protein 0.14 [0.07-0.23] 0.13 [0.06-0.23] 0.14 [0.06-0.25] 0.15 [0.06-0.23] 0.09 [0.04-0.18] 0.099

Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c.

*Including cardiovascular disease (coronary artery, myocardial infarction, and cerebrovascular diseases), hypertension, diabetes, dyslipidemia, and cancer.

Including past and current users.

Assessed at years 4.